Our first ever ESHRE sponsored symposium proved a hit with hundreds of delegates in attendance, eager to hear more about the latest research available in reproductive genetics and mosaicism.
Tony Gordon PhD, Vice President of Business Development at CooperGenomics gave the first talk on issues faced in reproductive genomics, addressing the challenges we face, citing the introduction of new technologies as a double-edged sword. More data is available, but we need to understand its clinical impact and how we translate those results to information that clinicians and patients can understand.
Santiago Munné PhD, co-founder of numerous genetic businesses including Reprogenetics and Recombine, presented a future-looking talk discussing where reproductive genetic technologies are going. This included non-invasive PGT-A, a new aneuploidy screening method that analyzes DNA in spent media rather than a biopsied sample.
This technique would avoid the challenges of biopsying, opening this type of technology up to a much wider audience.
A podcast of the event will be made available soon.